Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Anticoagulation Management After Intracerebral Hemorrhage

Initial Management

  • Control of hypertension is critically important in patients with atrial fibrillation, as uncontrolled hypertension is both a risk factor for recurrent intracerebral hemorrhage and for cardioembolic stroke, according to the American Heart Association 1
  • Target blood pressure should be normalized before considering any antithrombotic therapy, as recommended by the American College of Cardiology 1, 2

Risk Assessment

  • Age >75 years increases both stroke and bleeding risk, and female gender increases stroke risk, as noted by the American College of Cardiology 3, 4, 5
  • Hypertension increases both stroke and bleeding risk, according to the American Heart Association 1, 3
  • The CHA₂DS₂-VASc score can be used to assess stroke risk, with points assigned for age >75 years, hypertension, and female gender, as recommended by the American College of Cardiology 2, 6

Timing of Anticoagulation Resumption

  • During the waiting period before considering restarting anticoagulation, strict blood pressure control should be maintained, as recommended by the American Heart Association 1
  • Monitoring for signs of atrial fibrillation recurrence is essential, according to the American College of Cardiology 3, 5

Decision Algorithm for Anticoagulation

  • If the patient remains in sinus rhythm with adequate rate control, consider withholding anticoagulation and using aspirin 81-325 mg daily instead, as recommended by the American College of Cardiology 3, 5
  • If atrial fibrillation recurs, reassess the risk-benefit ratio of anticoagulation, according to the American College of Cardiology 3, 4

Common Pitfalls and Caveats

  • Elderly patients (≥75 years) have about twice the risk of serious bleeding complications during anticoagulation compared to younger patients, as noted by the American Heart Association 2
  • Regular reassessment of the need for anticoagulation is essential as the patient's risk factors may change over time, according to the American College of Cardiology 3, 5
  • Control of hypertension is essential before and during any antithrombotic therapy, as recommended by the American Heart Association 1

Follow-up Recommendations

  • Reevaluate the need for anticoagulation at regular intervals, according to the American College of Cardiology 3, 6
  • Monitor blood pressure closely and maintain strict control, as recommended by the American Heart Association 1
  • If anticoagulation is initiated, check INR at least weekly during initiation and monthly when stable, according to the American College of Cardiology 3, 4

REFERENCES